Postinfectious Irritable Bowel Syndrome and Gelsectan

Clinical trial NCT05045768 · COMPLETED

Trial details

NCT number: NCT05045768
Sponsor: Evangelismos Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2021-09-01
Primary completion: 2024-02-26
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.